article_metadata: Chao Deng Meng Yang Hong Jiang Renbin Wang Zhaojun Yang Hongliang Sun Huijuan Cui
article_metadata: 10.3389/fonc.2021.664809
article_metadata: Front Oncol
article_metadata: 2021 Sep 2;11:664809.
article_metadata: immune checkpoint inhibitors (icis) immune-related adverse events (iraes) non-small cell lung cancer (nsclc) programmed cell death-1(pd-1) tislelizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34540659/
article_metadata: Case Reports
article_metadata: PMC8443792
article_metadata: 34540659
article_metadata: Immune-Related Multiple-Organs Injuries Following ICI Treatment With Tislelizumab in an Advanced Non-Small Cell Lung Cancer Patient: A Case Report
article_metadata: 2021